Our findings suggest that the airway inflammation that characterizes CF lung disease plays a major role in the positive clinical responses to CFTR modulator therapy, and we propose a model with a direct relationship between airway inflammation and CFTR rescue (Figure 5). This evidence concerns the gene CFTR and lung disorder.